[The prognosis of drug therapy efficacy in ventricular rhythm disorders by the level of intracellular Ca2+ in the lymphocytes of patients with ischemic heart disease].
Liusov
V A
VA
Volov
N A
NA
Dibirova
G O
GO
Uteshev
D B
DB
D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000097:blood / Q000150:complications / Q000188:drug therapy; D001145:Arrhythmias, Cardiac / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D002118:Calcium / Q000097:blood*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006352:Heart Ventricles; D006801:Humans; D008214:Lymphocytes / Q000187:drug effects* / Q000378:metabolism; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D005082:Physical Exertion; D011224:Prazosin / Q000008:administration & dosage; D011379:Prognosis; D011433:Propranolol / Q000008:administration & dosage
D011433:Propranolol; D002118:Calcium; D011224:Prazosin
Prognozirovanie éffektivnosti medikamentoznoĭ terapii zheludochkovykh narusheniĭ ritma po urovniu vnutrikletochnogo Ca2+ v limfotsitakh bol'nykh ishemicheskoĭ bolezn'iu serdtsa.